Prescription drug dispensing profiles for one million children: A population-based analysis

European Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2013, Pages 581-588

  Zhang, Tingting ^a,b,c   Smith, M Anne ^b,c   Camp, Pat G ^d,e   Shajari, Salomah ^b   MacLeod, Stuart M ^f   Carleton, Bruce C ^a,b,c,g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^e ST PAUL S HOSPITAL   (Canada)

^f PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Children; Population based; Prescription dispensing rate

Indexed keywords

AMFEBUTAMONE; AMOXICILLIN; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; CEPHALOSPORIN DERIVATIVE; CITALOPRAM; CLARITHROMYCIN; CORTICOSTEROID; DEXAMPHETAMINE; FLUOXETINE; MACROLIDE; METHYLPHENIDATE; ORAL CONTRACEPTIVE AGENT; PENICILLIN DERIVATIVE; PHENELZINE; RESPIRATORY TRACT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SEX HORMONE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ARTICLE; CANADA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; EUROPE; FEMALE; HUMAN; INFANT; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; AGE FACTORS; AMBULATORY CARE; BRITISH COLUMBIA; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; EUROPE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; UNITED STATES;

EID: 84877127226     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1343-1     Document Type: Article

References (55)

1. Statistics Canada (2011) Population by sex and age group, by province and territory. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo31a- eng.htm. Accessed 1 February 2012
2. Khaled LA, Ahmad F, Brogan T, Fearnley J, Graham J, MacLeod S (2003) Prescription medicine use by one million Canadian children. Paediatr Child Health 8 (Suppl A):6A-56A
3. Demers V, Melo M, Jackevicius C et al (2008) Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. CMAJ 178:405-409. doi: 10.1503/cmaj.070587
4. British Columbia Ministry of Health (2012) All PharmaCare Plan descriptions. http://www.health.gov.bc.ca/pharmacare/plans/index.html. Accessed 1 February 2012
5. Sturkenboom MCJM, Verhamme KMC, Nicolosi A et al (2008) Drug use in children: cohort study in three European countries. BMJ (Clin Res Ed) 337:a2245-a2245. doi: 10.1136/bmj.a2245
6. British Medical Association (2012) Media centre - general practitioners. http://www.bma.org.uk/press-centre/pressgps.jsp#.T8H9zlJlLOy. Accessed 1 February 2012
7. Protti D, Smit C (2006) The Netherlands: another European country where GPs have been using EMRs for over twenty years. http://www.healthcareimc.com/ bcovers/PDFS/TheNetherlands.pdf. Accessed 1 February 2012
8. Cazzato T, Pandolfini C, Campi R, Bonati M (2001) Drug prescribing in out-patient children in Southern Italy. Eur J Clin Pharmacol 57:611-616. doi: 10.1007/s0022800356
9. Brownell M, De Coster C, Penfold R, et al (2008) Manitoba child health atlas update. http://mchp-appserv.cpe.umanitoba.ca/reference/Child-Health-Atlas- Update-Final.pdf. Accessed February 2012
10. British Columbia Stats (2006) Statistical profile of aboriginal peoples. Aboriginal peoples compared to the non-aboriginal population with emphasis on labour market and post secondary issues. http://www.bcstats.gov.bc.ca/data/ cen01/abor/aborbc.pdf. Accessed 1 February 2012
11. BC Stats (2011) P.E.O.P.L.E software. http://www.bcstats.gov.bc.ca/ StatisticsBySubject/Demography/PopulationProjections.aspx. Accessed 1 February 2012
12. WHO Collaborating Centre for Drug Statistics Methodology (2010) ATC/DDD index. http://www.whocc.no/atc-ddd-index/. Accessed 1 February 2012
13. Clavenna A, Berti A, Gualandi L, Rossi E, De Rosa M, Bonati M (2009) Drug utilisation profile in the Italian paediatric population. Eur J Pediatr 168:173-180. doi: 10.1007/s00431-008-0725-y
14. Thrane N, Sorensen HT (1999) A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr 88:1131-1136
15. Schirm E, van den Berg P, Gebben H, Sauer P, Jong-van D, den Berg L (2000) Drug use of children in the community assessed through pharmacy dispensing data. Br J Clin Pharmacol 50:473-478. doi: 10.1046/j.1365-2125.2000. 00275.x
16. Faber A, de Jong-van den Berg LT, van den Berg PB, Tobi H (2005) Psychotropic co-medication among stimulant-treated children in the Netherlands. J Child Adolesc Psychopharmacol 15:38-43. doi: 10.1089/cap.2005.15.38
17. Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K (2006) Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197-206. doi: 10.1089/cap.2006.16.197
18. Knellwolf AL, Deligne J, Chiarotti F et al (2008) Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol 64:311-317. doi: 10.1007/s00228-007-0401-6
19. Volkers AC, Heerdink ER, van Dijk L (2007) Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiol Drug Saf 16:1054-1062. doi: 10.1002/pds.1430
20. Zito JM, Safer DJ, Berg LT, et al (2008) A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatr Mental Health 2:26. doi: 10.1186/1753-2000-2-26
21. Clavenna A, Andretta M, Pilati P et al (2011) Antidepressant and antipsychotic use in an Italian pediatric population. BMC Pediatr 11:40. doi: 10.1186/1471-2431-11-40
22. Breton JJ, Bergeron L, Valla JP et al (1999) Quebec child mental health survey: prevalence of DSM-III-R mental health disorders. J Child Psychol Psychiatry Allied Discip 40:375-384
23. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS (2007) Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 161:857-864. doi: 10.1001/archpedi.161.9.857
24. Ford T, Goodman R, Meltzer H (2003) The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 42:1203-1211. doi: 10.1097/00004583-200310000-00011
25. Lecendreux M, Konofal E, Faraone SV (2010) Prevalence of attention deficit hyperactivity disorder and associated features among children in France. J Atten Disord 15:516-524. doi: 10.1177/1087054710372491
26. Huss M, Holling H, Kurth BM, Schlack R (2008) How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry 17(Suppl 1):52-58. doi: 10.1007/s00787-008-1006-z
27. Dopfner M, Breuer D, Wille N, Erhart M, Ravens-Sieberer U (2008) How often do children meet ICD-10/DSM-IV criteria of attention deficit-/ hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample - results of the BELLA study. Eur Child Adolesc Psychiatry 17(Suppl 1):59-70. doi: 10.1007/s00787-008-1007-y
28. Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A (2004) Italian attention-deficit/hyperactivity disorder registry. Pediatrics 114:514
29. Centres for Disease Control and Prevention (CDC) (2003) Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder. CDC-MMWR Weekly 54:842-847. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5434a2.htm. Accessed 1 February 2012
30. Ministry of Children and Family Development (2003) Child and youth mental health plan for British Columbia. http://www.mcf.gov.bc.ca/mental-health/pdf/ cymh-plan.pdf. Accessed 1 February 2012
31. National Institute for Health and Clinical Excellence (2006) Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. http://www.nice.org. uk. Accessed 1 February 2012
32. Vitiello B (2008). An international perspective on pediatric psychopharmacology. Int Rev Psychiatry 20(2):121-126. doi: 10.1080/ 09540260801887710
33. Heyman I, Santosh P (2002) Pharmacological and other physical treatments. In: Rutter M, Taylor E (eds) Child and adolescent psychiatry, 4th ed. Blackwell Science, Oxford, pp 998-1018
34. Taylor E, Dopfner M, Sergeant J et al (2004) European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7-I30. doi: 10.1007/s00787-004-1002-x
35. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington DC
36. American Academy of Pediatrics (2001) Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108:1033-1044
37. National Institute for Health and Clinical Excellence (2009) Depression in children. Clinical knowledge summaries. http://www.cks.nhs.uk/depression-in- children/management/scenario-depression-in-children#344099006. Accessed 1 February 2012
38. Son SE, Kirchner JT (2000) Depression in children and adolescents. Am Fam Physician 62:2297-2308
39. Hsia Y, Maclennan K (2009) Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK. Eur J Epidemiol 24:211-216. doi: 10.1007/s10654-009-9321-3
40. Watson R (2003) EU health ministers reject proposal for limited direct to consumer advertising. BMJ (Clinical Res Ed) 326:1284. doi: 10.1136/bmj.326. 7402.1284-b326/7402/1284-b
41. Mintzes B, Barer ML, Kravitz RL et al (2003) How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 169:405-412
42. Ufer M, Meyer SA, Junge O et al (2007) Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 16:1153-1160. doi: 10.1002/pds.1405
43. Health Canada (2000) Risk of important drug interactions between St. John's wort and prescription drugs. http://www.hc-sc.gc.ca/dhp-mps/medeff/ advisories-avis/prof/-2000/hypericum-perforatum-hpc-cps-eng.php. Accessed 1 February 2012
44. Lawvere S, Mahoney MC (2005) St. John's wort. Am Fam Physician 72:2249-2254
45. Marra F, Monnet DL, Patrick DM et al (2007) A comparison of antibiotic use in children between Canada and Denmark. Ann Pharmacother 41:659-666. doi: 10.1345/aph.1H293
46. de Jong J, van den Berg PB, de Vries TW, de Jong-vanden Berg LT (2008) Antibiotic drug use of children in the Netherlands from 1999 till 2005. Eur J Clin Pharmacol 64:913-919. doi: 10.1007/s00228-008-0479-5
47. Matthys J, De Meyere M, van Driel ML, De Sutter A (2007) Differences among international pharyngitis guidelines: not just academic. Ann Fam Med 5:436-443. doi: 10.1370/afm.741
48. Gould LM, van der Meer JWM, Harbarth S, Monnet DL (2007) Cultural and socioeconomic determinants of antibiotic use. In: Gould LM, van der Meer J (eds) Antibiotic policies - fighting resistance. Springer, Berlin, pp 29-40
49. British Columbia Health Services (2003) Guidelines and protocols. Diagnosis and management of sore throat. http://iskra.bfm.hr/upload/sore-throat- british-colombia.pdf. Accessed 20 May 2012
50. US Department of Health and Human Services (2005) National Guideline Clearinghouse. Acute pharyngitis in children 2-18 years old. http://guideline.gov/content.aspx?id=25757. Accessed 20 May 2012
51. Dagnelie C, Zwart S, Balder F, Romeijiders A, Geijer R (1999) NHG-standaard Acute Keelpijn (eerste herziening). [Guideline on acute tonsillitis of the Dutch College of General Practitioners, first revision.] Huisarts Wet 42:271-278.
52. Scottish Intercollegiate Guidelines Network (2010) Management of sore throat. http://www.sign.ac.uk/guidelines/fulltext/117/index.html. Accessed 15 May 2012
53. Palmer DA, Bauchner H (1997) Parents' and physicians' views on antibiotics. Pediatrics 99(6):E6
54. Clavenna A, Bonati M (1996) Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child 96:590-595. doi: 10.1136/adc.2010.183541
55. Rossignoli A, Clavenna A, Bonati M (2007) Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005. Eur J Clin Pharmacol 63:1099-1106. doi: 10.1007/s00228-007-0376-3